GSK’s global supply chain is intricate, involving both primary (active pharmaceutical ingredients manufacturing) and secondary (finished product creation) locations. Therefore, the first challenge was ...
GSK has pledged to 100% use of renewable across the company by 2025, and an 80% reduction in carbon emissions by 2030 en route to net zero across all its supply chain – including purchased goods ...
GlaxoSmithKline said it will raise prices ... industry groups on identifying inefficiencies in the U.S. drug supply chain and has provided consulting work to hedge fund billionaire John Arnold ...
Drugmakers and analysts fear retaliation from Brussels will only exacerbate Europe’s drug supply issues. After raising ...
Pharmaceutical Technology on MSN5d
Amid deglobalising trade, experts seek AI safeguards for clinical trial supplyInnovation, collaboration, and regulatory reform were on the agenda at the 2025 Clinical Trial Supply Europe conference.
Pharmaceutical majors AstraZeneca and GSK have partnered with competitor Takeda and nine suppliers to accelerate the adoption ...
The site will house around 3,000 people – including GSK's global leadership team, and teams supporting R&D, the supply chain, commercial operations, corporate functions, and HIV joint venture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback